@hdtbio has taken the lead in licensing partnerships in developing nations to locally develop, manufacture and distribute vaccines to fight #COVID19 and future pandemics. Partnerships now in #India, #Brazil and #Korea - more TBA. #globalhealth
https://t.co/1Y4oMhuRgK
It has now been 5 days, and neither @etihad nor @DelhiAirport have any idea where my 31kg suitcase is. With 0 response and 0 follow up, I am absolutely appalled at both service providers. Resorting to Twitter for some ACTION.
Gennova submitted proposed Phase II and Phase III study which is approved by DCGI
The study will be conducted in India at approximately 10-15 sites in Phase II and 22-27 sites in Phase III
The mRNA-based COVID-19 vaccine program was partly funded by Department of Biotechnology
India’s first mRNA-based #COVIDVaccine receives nod from DCGI to move into Phase-2 and Phase-3 trial. Gennova Biopharmaceuticals Ltd which is the Pune-based biotechnology company is working on mRNA-based COVID-19 vaccine- #HGCO19.
We've been using this device for last 1.5 years, even before COVID came. We haven't seen a single positive case on the campus yet: Dr. Rajah Vijay Kumar- Director and Chief Scientific Officer, CARD - Scalene Cybernetics Limited, Bangalore
https://t.co/jghcajZuXf
#Breaking: In collaboration with @CRISPRTX, we announced FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for CTX001 under clinical investigation for severe sickle cell disease and transfusion-dependent beta thalassemia: https://t.co/l6XNM6P0xR